Back
Manufacturing & IndustryInvestment & FDI

Partnership between 'Saïdal' and Swiss 'Roche' to Localize Breast Cancer Drug Manufacturing in Algeria

September 10, 2026اقتصاد | الإذاعة الجزائريةradioalgerie.dzTranslated from Arabic
Partnership between 'Saïdal' and Swiss 'Roche' to Localize Breast Cancer Drug Manufacturing in Algeria

The 'Saïdal' group signed a partnership contract with the Swiss company 'Roche' in Algiers this Thursday, aimed at localizing the production of breast cancer drugs at the factory belonging to the public group located in El Harrach (the capital). The contract signing ceremony was overseen by the Minister of Pharmaceutical Industry, Wassim Gouidri, and attended by the General Director of the pharmaceutical group, Younes Bouarara, the General Director of 'Roche' Algeria, Mohamed Ali Oumani, as well as the Ambassador of the Swiss Confederation to Algeria, Marion Waslet-Krobski, along with executives from both companies.

Read Full Article
Share on social media

Related Articles

Manufacturing & Industry
Integrated Phosphate.. Completion of Industrial Water Connection Projects Before the End of 2026

Integrated Phosphate.. Completion of Industrial Water Connection Projects Before the End of 2026

The Minister of Water Resources, Lounes Bouzguza, emphasized the necessity of completing the connection works for the integrated phosphate project in both El Hadba and Oued Kebrit with industrial water before the end of 2026, stressing the need to accelerate the pace of achievement and adhere to the applicable technical standards and specifications. This came during his chairing of a working session yesterday, Thursday, dedicated to monitoring the progress of the industrial water connection projects related to the project, where the minister stressed the need to intensify efforts and increase the pace of achievement, according to a statement from the Ministry of Water Resources. Read the full content on Echourouk Online.

Sep 11, 2026echoroukonline.com

News Disclaimer: Articles are curated from third-party sources for informational purposes. We do not verify or endorse the accuracy of third-party content.